期刊文献+

艾司洛尔治疗急性心肌梗死冠脉介入治疗围术期交感风暴的临床疗效 被引量:2

下载PDF
导出
摘要 目的探讨艾司洛尔治疗急性心肌梗死急诊冠脉介入治疗(PCI)患者围术期,反复发作持续性室速/室颤-交感风暴的临床疗效及安全性。方法 427例急性心肌梗死行急诊PCI患者,在围术期发作交感风暴45例,占10.5%,平均年龄59.4±9.3岁。分为常规治疗组(24例)和艾司洛尔组(21例),常规组使用静脉胺碘酮,配合电复律/电除颤治疗,艾司洛尔组在胺碘酮无效的基础上加用静脉艾司洛尔,或直接艾司洛尔治疗。结果艾司洛尔组终止交感风暴的成功率显著高于常规组;艾司洛尔给药后室速/室颤复发次数明显减少,相应除颤次数较常规组少;艾司洛尔组给药后心率、收缩压、舒张压较常规组明显降低,未发生不能维持的低血压状态和严重缓慢性心律失常。结论成功急诊冠脉介入治疗,及时的电复律/电除颤和使用β受体阻滞剂艾司洛尔,可有效控制急性心肌梗死冠脉介入治疗围术期交感风暴的复发。
出处 《中国医刊》 CAS 2011年第9期48-49,共2页 Chinese Journal of Medicine
  • 相关文献

参考文献8

二级参考文献10

  • 1郭继鸿.β受体阻滞剂应当成为快速心律失常治疗的基础用药[J].中国心脏起搏与心电生理杂志,2005,19(5):331-334. 被引量:80
  • 2Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a muhidrug regimen in the developing world: a cost-effectiveness analysis[J]. Lancet, 2006,19,368(9536) :679
  • 3Lanza CA, Fox K, Crea F. Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing[ J ]. Adv Cardiol,2006,43:1
  • 4Siddiqui A, Kowey PR. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies[ J]. Curr Opin Cardiol,2006,21(5) :517
  • 5Viitasalo M, Oikarinen L, Swan H, et al. Effects of beta-blocker therapy on ventricular repolarization documented by 24 h electrocardiography in patients with type 1 long-QT syndrome[J]. J Am Coll Cardiol,2006,48 (4) :747
  • 6Pedersen ME, Cockcroft JR. The latest generation of beta-blockers :new pharmacologic properties [ J ]. Curr Hypertens Rep, 2006, 8(4):279
  • 7Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary : a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines[J]. Eur Heart J, 2006,27(16) :1 979
  • 8Zipes DP, Carom AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sadden cardiac death-executive summary : a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines [ J ]. Eur Heart J, 2006,27 ( 17 ) :2 099
  • 9Blomstrom C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC Guidelines for the management of patients with supraventricular arrhythmias [ J ]. J Am Coll Cardiol,2003,42 ( 8 ) : 1493
  • 10Adamson PB, Gilbert EM. Reducing the risk of sudden death in heart failure with beta-blockers[J]. J Card Fail,2006,12(9) :734

共引文献76

同被引文献17

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部